MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617062835 A) filed by Basilea Pharmaceutica International AG, Allschwil on May 18, 2026, for Citrate Coordination Complex Of An Orally-Delivered Beta-Lactamase Inhibitor And Uses Thereof.
Inventors include Dickson, David P.; Drager, Anthony; Rongala, Gopinath; and Zulli, Allison L..
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: Disclosed herein is a compound that is (R)-(2-(3-((((2-ethylbutanoyl)oxy)methoxy)carbonyl)-2-hydroxyphenyl)-1-propionamidoethyl)boronic acid citrate coordination complex, or a pharmaceutically acceptable salt or solvate thereof. Also disclosed herein are methods of treating a bacterial with a compound that is (R)-(2-(3-((((2- ethylbutanoyl)oxy)methoxy)carbonyl)-2-hydroxyphenyl)-1-propionamidoethyl)boronic acid citrate coordination complex, or a pharmaceutically acceptable salt or solvate thereof in combination with ceftibuten.
Disclaimer: Curated by HT Syndication.
